Photo Quiz: Facial Hyperpigmentation - December 1, 2008

December 1, 2008 Table of Contents

Photo Quiz

Facial Hyperpigmentation

LU�S PAULO C. TRINDADE e SILVA, MD; FRANCISCO LU�S, MD; and HEIDY CABRERA, MD, Hospital Sousa Martins, Portugal

Am Fam Physician.�2008�Dec�1;78(11):1297-1298.

Figure 1.

A 73-year-old woman presented with dizziness, uncomfortable chest pressure that worsened during exertion, and headache; her symptoms began two days earlier. The patient had a history of hypertension and atrial fibrillation. She had a cerebral vascular accident 11 years earlier that led to visual and motor sequelae. Since then, she had been taking 200 mg of amiodarone (Pacerone), 20 mg of enalapril (Vasotec), and 150 mg of aspirin daily. Physical examination revealed bradycardia (42 beats per minute) as well as asymptomatic, blue-gray to purple facial pigmentation (Figure 1). Thyroid, lung, liver, and kidney function and autoimmunity test results were normal. At the follow-up visit, the patient's heart rate was normal without the use of amiodarone, but her skin remained discolored.

Question

Based on the patient's history and physical examination, which one of the following is the most likely diagnosis?

A. Amiodarone-induced hyperpigmentation.
B. Chloasma.
C. Erythema dyschromicum perstans.
D. Localized discoid lupus erythematosus.
E. Riehl melanosis.

DISCUSSION

The answer is A: amiodarone-induced hyperpigmentation. Amiodarone is an iodine-rich medication that is widely used to manage cardiac arrhythmias. It has numerous adverse effects, such as toxicity of the lungs, thyroid, liver, eyes, and nerves. A blue-gray discoloration of the skin is an uncommon adverse effect caused by the ultraviolet accumulation of lipofuscin in dermal macrophages. The appearance of the discoloration depends on the dosage of amiodarone and duration of use, and may regress upon cessation of the treatment.1 Biopsy confirms skin impregnation of iodine with deposition of brown pigment within dermal microphages (Figure 2).

Chloasma, or melasma, is an acquired hypermelanosis that is common during pregnancy. It is characterized by irregular, light brown to gray-brown macules involving the face, particularly the cheeks, forehead, nose, upper lip, and chin. Histologic findings include increased activity and numbers of melanocytes, with sparse or absent inflammation.2

Erythema dyschromicum perstans (ashy dermatosis) is an acquired, benign condition characterized by asymptomatic, slate-gray to violet or blue macules. The etiology of the condition is unknown. Its histologic pattern is relatively nonspecific with pigment incontinence, peri-vascular lymphohistiocytic infiltrate, and an immune-associated antigen expression in keratinocytes.3

Localized discoid lupus erythematosus occurs on sun-exposed areas of the face, particularly the bridge of the nose, lower eyelids, lower lip, and ears. Initially, active lesions are red or violet, with lighter scaly centers and darker outer rings. Antibodies against double-stranded DNA are almost always absent. Histopathologic alterations include atrophy of the epidermis, hyperkeratosis, follicular plugging, vacuolar degeneration of the basal cell layer with marked melanin deposits in the upper dermis following basal cell damage, and heavy peri-adnexal mononuclear cell infiltration.4

Figure 2.

Biopsy findings confirming skin impregnation of iodine with deposition of brown pigment within dermal microphages. (A) Hematoxylin stain. (B) Fontana-Masson stain.

Selected Differential Diagnosis of Facial Hyperpigmentation

Condition	Characteristics
Amiodarone-induced hyperpigmentation	Blue-gray facial pigmentation with accumulation of lipofuscin in dermal macrophages
Chloasma	Irregular, light brown to gray-brown macules with increased activity and numbers of melanocytes with sparse or absent inflammation
Erythema dyschromicum perstans	Slate-gray to violet or blue macules with perivascular lymphohistiocytic infiltrate; pigment incontinence and immune-associated antigen expression in keratinocytes
Localized discoid lupus erythematosus	Erythematous lesions with vacuolar degeneration of the basal cell layer and marked melanin deposits in the upper dermis following basal cell damage; atrophy of the epidermis; hyperkeratosis; follicular plugging
Riehl melanosis	Spotty brown-gray facial pigmentation with lymphohistiocytic infiltrate in the upper dermis

Riehl melanosis is a spotty, brown-gray facial pigmentation most pronounced on the forehead and the zygomatic and temporal regions. It occurs in persons with a history of exposure to cosmetics. Severe cases may appear black, purple, or blue-black. Histologic findings include a lymphohistiocytic infiltrate in the upper dermis.5

Address correspondence to Lu�s Paulo C. Trindade e Silva, MD, at luis. paulo@sapo.pt. Reprints are not available from the authors.

Author disclosure: Nothing to disclose.

REFERENCES

1. Siddoway �LA. �Amiodarone: guidelines for use and monitoring. �Am Fam Physician. �2003;68(11):2189–2196.

2. Victor �FC, Gelber �J, Rao �B. �Melasma: a review. �J Cutan Med Surg. �2004;8(2):97–102.

3. Schwartz �RA. �Erythema dyschromicum perstans: the continuing enigma of Cinderella or ashy dermatosis. �Int J Dermatol. �2004;43(3):230–232.

4. Pramatarov �KD. �Chronic cutaneous lupus erythematosus. �Clin Dermatol. �2004;22(2):113–120.

5. Rorsman �H. �Riehl's melanosis. �Int J Dermatol. �1982;21(2):75–78.

The editors of AFP welcome submissions for Photo Quiz. Guidelines for preparing and submitting a Photo Quiz manuscript can be found in the Authors' Guide at http://www.aafp.org/afp/photoquizinfo. To be considered for publication, submissions must meet these guidelines. E-mail submissions to afpphoto@aafp.org.

Copyright � 2008 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact afpserv@aafp.org for copyright questions and/or permission requests.